Antiviral chemistry & chemotherapy

(Antivir Chem Chemother) ISSNs: 0956-3202,

References in Antiviral chemistry & chemotherapy:

Search this table:

Title	Authors	Year
Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates.	Samuele A, Bisi S, Kataropoulou A, La Regina G, Piscitelli F, Gatti V, Silvestri R, Maga G	2011
Anti-HIV-1 activity in vitro of ceftazidime degradation products.	Hobi R, Hübscher U, Neftel K, Alteri E, Poncioni B, Walker MR, Woods-Cook K, Schneider P, Lazdins JK	2001
Nitroimidazoles Part 6. Synthesis, structure and in vitro anti-HIV activity of new 5-substituted piperazinyl-4-nitroimidazole derivatives.	Al-Masoudi NA, Al-Soud YA, De Clercq E, Pannecouque C	2007
Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].	Taylor DL, Ahmed PS, Tyms AS, Wood LJ, Kelly LA, Chambers P, Clarke J, Bedard J, Bowlin TL, Rando RF	2000
HIV-1 resistance profile of the novel nucleoside reverse transcriptase inhibitor beta-D-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (Reverset).	Geleziunas R, Gallagher K, Zhang H, Bacheler L, Garber S, Wu JT, Shi G, Otto MJ, Schinazi RF, Erickson-Viitanen S	2003
Indolyl aryl sulphones as HIV-1 non-nucleoside reverse transcriptase inhibitors: synthesis, biological evaluation and binding mode studies of new derivatives at indole-2-carboxamide.	De Martino G, La Regina G, Ragno R, Coluccia A, Bergamini A, Ciaprini C, Sinistro A, Maga G, Crespan E, Artico M, Silvestri R	2006
Non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis and biological evaluation of novel quinoxalinylethylpyridylthioureas as potent antiviral agents.	Campiani G, Fabbrini M, Morelli E, Nacci V, Greco G, Novellino E, Maga G, Spadari S, Bergamini A, Faggioli E, Uccella I, Bolacchi F, Marini S, Coletta M, Fracasso C, Caccia S	2000
Variability in the PR and RT genes of HIV-1 isolated from recently infected subjects.	Turner D, Roldan A, Brenner BG, Moisi DD, Routy JP, Wainberg MA	2004
Mutations and polymorphisms associated with antiretroviral drugs in HIV-1C-infected African patients.	Doualla-Bell F, Gaseitsiwe S, Ndungú T, Modukanele M, Peter T, Novitsky V, Ndwapi N, Tendani G, Avalos A, Wester W, Bussmann H, Cardiello P, Marlink RG, Moffat H, Thior I, Wainberg MA, Essex M	2004
An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.	Chamorro C, Camarasa MJ, Pérez-Pérez MJ, De Clercq E, Balzarini J, San Félix A	1998
Synthesis and antiviral activity of some 5'-N-phthaloyl-3'-azido-2',3'-dideoxythymidine analogues.	Balzarini J, De Clercq E, Kaminska B, Orzeszko A	2003
Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitors.	Chimirri A, Monforte P, Rao A, Zappalà M, Monforte AM, De Sarro G, Pannecouque C, Witvrouw M, Balzarini J, De Clercq E	2001
Kinetics of inhibition of HIV type 1 reverse transcriptase-bearing NRTI-associated mutations by apricitabine triphosphate.	Frankel FA, Coutsinos D, Xu H, Wainberg MA	2007
Factors affecting template usage in the development of K65R resistance in subtype C variants of HIV type-1.	Coutsinos D, Invernizzi CF, Xu H, Brenner BG, Wainberg MA	2010
Selection of resistance-conferring mutations in HIV-1 by the nucleoside reverse transcriptase inhibitors (+/-)dOTC and (+/-)dOTFC.	Richard N, Salomon H, Oliveira M, Rando R, Mansour T, Gu Z, Wainberg MA	2000
Anti-HIV-1 activity of benzothiadiazine dioxide.	Martinez A, Gil C, Castro A, Perez C, Witvrouw M, Pannecouque C, Balzarini J, De Clercq E	2001
Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.	Maruyama T, Kozai S, Yamasaki T, Witvrouw M, Pannecouque C, Balzarini J, Snoeck R, Andrei G, De Clercq E	2003
Structure-activity relationship studies on a novel family of specific HIV-1 reverse transcriptase inhibitors.	Bonache MC, Chamorro C, Lobatón E, De Clercq E, Balzarini J, Velázquez S, Camarasa MJ, San-Félix A	2003
Synthesis, solution conformation and anti-HIV activity of novel 3'-substituted-2',3'-dideoxy-5-hydroxymethyluridines and their 4,5-substituted analogues.	Poznanski J, Bretner M, Kulikowski T, Balzarini J, Van Aerschot A, De Clercq E	2003
Treatment of visna virus infection in lambs with the acyclic nucleoside phosphonate analogue 9-(2-phosphonylmethoxyethyl)adenine (PMEA).	Thormar H, Georgsson G, Gunnarsson E, Naesens L, Torsteinsdóttir S, Balzarini J, De Clercq E	1998
In search of authentic inhibitors of HIV-1 integration.	Debyser Z, Cherepanov P, Van Maele B, De Clercq E, Witvrouw M	2002
Potent and selective inhibition of HIV and SIV by prostratin interacting with viral entry.	Witvrouw M, Pannecouque C, Fikkert V, Hantson A, Van Remoortel B, Hezareh M, De Clercq E, Brown SJ	2003
Inhibition of HIV infection by CXCR4 and CCR5 chemokine receptor antagonists.	De Clercq E, Schols D	2001
TSAO derivatives the first non-peptide inhibitors of HIV-1 RT dimerization.	Camarasa MJ, Velázquez S, San-Félix A, Pérez-Pérez MJ	2005

Showing 1 to 24 of 24 entries